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Abstract
Background: Cancer re-sequencing programs rely on DNA isolated from fresh snap frozen tissues, the preparation of which
is combined with additional preservation efforts. Tissue samples at pathology departments are routinely stored as formalin-
fixed and paraffin-embedded (FFPE) samples and their use would open up access to a variety of clinical trials. However, FFPE
preparation is incompatible with many down-stream molecular biology techniques such as PCR based amplification
methods and gene expression studies.
Methodology/Principal Findings: Here we investigated the sample quality requirements of FFPE tissues for massively
parallel short-read sequencing approaches. We evaluated key variables of pre-fixation, fixation related and post-fixation
processes that occur in routine medical service (e.g. degree of autolysis, duration of fixation and of storage). We also
investigated the influence of tissue storage time on sequencing quality by using material that was up to 18 years old.
Finally, we analyzed normal and tumor breast tissues using the Sequencing by Synthesis technique (Illumina Genome
Analyzer, Solexa) to simultaneously localize genome-wide copy number alterations and to detect genomic variations such
as substitutions and point-deletions and/or insertions in FFPE tissue samples.
Conclusions/Significance: The application of second generation sequencing techniques on small amounts of FFPE material
opens up the possibility to analyze tissue samples which have been collected during routine clinical work as well as in the
context of clinical trials. This is in particular important since FFPE samples are amply available from surgical tumor resections
and histopathological diagnosis, and comprise tissue from precursor lesions, primary tumors, lymphogenic and/or
hematogenic metastases. Large-scale studies using this tissue material will result in a better prediction of the prognosis of
cancer patients and the early identification of patients which will respond to therapy.
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Introduction
The advance of second generation sequencing techniques (454
sequencing, the Illumina Genome Analyzer (Solexa), the SOLiD
platform, the Polonator and the HeliScope Single Molecule
Sequencer technology) enables us to investigate many ‘‘-omes’’ of
patients material, such as genomes, transcriptomes,epigenomes and
miRNAomes [1,2,3]. The sequencing techniques are based on the
amplification of single DNA molecules and thereby provide, in a
sense, ‘digital’ information [4,5,6]. They are considerably less error-
prone to the ‘contamination’ between normal and diseased tissues
and are especially advantageous for the analysis of tumor tissues [7].
To date, cancer sequencing programs have relied on DNA
isolated from fresh frozen tissues, access to which can be limited
[8]. The use of preserved material, i.e. from tissue banks, could
help to avoid this limitation and would enable the reanalysis of
diverse clinical trials. A common and convenient way to store
tissues over long periods of time is to fix them in formaldehyde and
embed them in paraffin. Large collections of diseased and normal
tissues are stored at hospitals and provide an excellent source for
molecular genetic studies. However, the recovery of nucleic acids
from these tissue specimens is challenging. Not only does
formaldehyde lead to crosslinkages between DNA or RNA and
proteins, but it also results in the preparation of fragmented DNA.
Both factors restrict diverse genetic techniques like polymerase
chain reactions due to poor quantity, purity and length of the
RNA and DNA.
To take advantage of preserved patient tissue we investigated
the sample quality requirements of formaldehyde-fixed and
paraffin-embedded (FFPE) tissues and established a protocol for
the application of massively parallel short-read sequencing
approaches. We evaluated key variables of pre-fixation, fixation
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service (e.g. degree of autolysis, duration of fixation and of storage)
(Table 1). We also investigated the influence of tissue storage time
on sequencing quality by using material that was up to 18 years
old. Finally, we analyzed normal and tumor breast tissues using
the Sequencing by Synthesis (Illumina Genome Analyzer)
technology to simultaneously localize genome-wide copy number
alterations and to detect genomic variations such as substitutions
and point-deletions and/or insertions in FFPE tissue samples.
Results
Genome-wide parallel sequencing of snap frozen and
FFPE tissue DNA
For the comparison of snap frozen and FFPE tissue DNA we
prepared breast tissue samples from one patient, divided the tissue
in seven equal amounts and preserved them either as snap frozen
or as FFPE tissue with ischemic times ranging from 20 min. to
over 6 hours and fixation times from 24 to 72 hours (Table 1).
After six months storage time, DNA was extracted, quality
controlled by aid of a Bioanalyzer array and sequenced with the
Sequencing by Synthesis technology (SBS). Test DNA extractions
using the QIAamp, Arcturus PicoPure and Macherey-Nagel DNA
extraction kits yielded equally successful sequencing results and
therefore further experiments were performed according to the
Qiagen protocol (data not shown). Tissue storage conditions
followed those used most frequently in routine pathology
department protocols. The sequencing resulted in approximately
3 to 5 million reads with 2 to 3 million mappable unique fragments
per sample (Table 2). For a visualization of the fragment
distributions we divided each chromosome in 300 equal sized
parts (‘bins’) and calculated the fragment number for each bin.
Using these 300 bins per chromosome we found a very similar
distribution of fragments over all chromosomes (Figure 1) for snap
frozen as well as for FFPE tissue DNA. Comparing the readcounts
per set unit (bin) for snap frozen and FFPE tissue as a measure of
coverage coherence, we calculated the Pearson correlation
coefficient and found a median correlation of bincounts of 0.82
for snap frozen and FFPE tissues. We also used genomic bin sizes
of 50, 100, 250, 500 and 1000 Kb and stratified the correlation
coefficients by the GC content of the bins (Supplementary Figure
S1). Bins with the most common GC content of approximately
40% have correlation values of approximately 0.97. The
dependency of correlation values from GC content is decreasing
with larger bin sizes though and is therefore likely a consequence
of low coverage. Similar findings were observed for technical
replicates (Supplementary Figure S2). In both cases the majority of
correlation coefficients are above 0.6 and the variability decreases
with increasing bin sizes. Thus, overall fragment numbers, aligned
fragments and chromosome-wise coverage are similar for snap
frozen and FFPE tissues, proving that fresh FFPE tissues can be
used for high throughput re-sequencing approaches.
Sequencing of up to 18 years old preserved tissue
material
Most of the tissues stored in biobanks are several years old and
clinical trials date back to at least ten year collection times.
Therefore, it would be highly desirable to include tissue samples
that have been stored long-term for genome-wide sequencing
techniques. In addition, studies of rare clinical diseases such as
Von Hippel-Lindau or Li-Fraumeni syndrome would become
more feasible to perform. Sequencing by Synthesis (SBS) of snap
frozen - and FFPE preserved tissue samples that were 14 and 18
years old resulted in approximately 1 million and 4 million aligned
reads with an even distribution over all chromosomes. Median
correlation of bincounts for snap frozen and FFPE tissue was
found to be very similar to recent tissue values at 0.84. Thus, tissue
storage time has a minor influence on sequence quality. It would
be interesting to analyze even older material in the same manner.
Detection of CNA and nucleotide-specific genomic
alterations in breast tumors
In addition to normal tissue samples, we also used tumor tissue
samples to investigate copy number alterations (CNA) and mutation
Table 1. Snap frozen and FFPE tissue samples used for
sequencing.
Sample
ID Tissue
Age
(years)
Ischemia
(min.) Fixation method
ID-1.0 Breast - normal 1 ,20 Snap frozen
ID-1.1 Breast - normal 1 ,20 24 hrs formaldehyde
ID-1.3 Breast - normal 1 60 24 hrs formaldehyde
ID-1.7 Breast - normal 1 360 24 hrs formaldehyde
ID-1.6 Breast - normal 1 180 72 hrs formaldehyde
ID-1.8 Breast - normal 1 360 72 hrs formaldehyde
ID-22.1 Breast - normal 18 ,20 Snap frozen
ID-22.2 Breast - normal 18 ,20 24 hrs formaldehyde
ID-02.15 Breast -tumor 14 ,20 Snap frozen
ID-02.48 Breast - tumor 14 ,20 24 hrs formaldehyde
doi:10.1371/journal.pone.0005548.t001
Table 2. Sequencing results, NE in snap frozen and FFPE tissues.
Sample ID Reads (million) unique aligned reads (million) SNPs known SNPs common SNPs (%)
ID-1.0 3,217 2,399 3419 1128
ID-1.1 3,217 1,373 6804 1461 81.4
ID-1.3 2,604 1,621 5413 1261 83.9
ID-22.1 3,296 2,369 9503 1567
ID-22.2 3,047 1,509 12734 1495 87.3
ID-02.15 2,074 1,521 2839 955
ID-02.48 2,631 0.92 6348 1303 89.8
For each set, ‘common SNPs’ were calculated in relation to the snap frozen samples.
doi:10.1371/journal.pone.0005548.t002
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and – as recently introduced in genetic counseling procedures – as
diagnostic tool for children with mental retardation of unknown
origin [9,10]. The identification of tumor mutations is essential for
the layout of a calculated chemotherapy. For example, tyrosine
kinase inhibitors (TKIs), such as gefitinib and erlotinib, are only
efficient in patients without K-ras mutations [11]. Up to now the
detection of CNAs and mutations required that two different
techniques be employed in routine clinical diagnostics: CNAs are
determined by comparative genomic hybridization (CGH) arrays
and mutations are found by conventional sequencing techniques.
With the power of second generation sequencing techniques, both
sets of information will be achieved in one process. Along this line,
we provide here the combined data for breast tumor tissues, both
snap frozen as well as FFPE tissues, using single SBS approaches.
For these experiments, breast tumor tissues were enriched for at
least 70% tumor cell content by macro-dissections. DNA libraries
for the Illumina Genome Analyzer (Solexa) were then prepared and
sequenced. We received approximately 1 million reads with 0.5
million unique mappable fragments. Using the DNAcopy software
in R [12] we found gains of DNA on chromosome 8 and 20
(Figure 2A). For chromosome 8, a fine-mapping of copy number
alterations revealed gain of DNA between the chromosomal
localizations 90.32 Mb and 146.27 Mb with a small disruption
between 137.06 Mb–139.4 Mb (Figure 2B). The CNAs found were
identical for snap frozen - and FFPE – material. They also
corresponded to frequent alterations found in breast tumors in
general, underlining the reliability of the sequencing technique [13].
Using one eighth of each Illumina Genome Analyzer (Solexa)
run sequencing capacity, the resolution with regard to CNAs lies at
approximately 15 Kb with 10 fragments per bin and can be easily
improved by additional sequencing. In comparison, the resolution
of the 244 K Array from Agilent, a frequently used array in
clinical settings, lies at approximately 45 Kb with 5 oligos. In
addition to CNA information, second generation sequencing
allows one to investigate genomic alterations, such as substitutions,
deletions and insertions and therefore will be a basic tool for
routine clinical diagnostics in the future.
In addition to CNAs, we also calculated nucleotide exchange
(NE) rates for all samples. In general, we found a NE probability of
0.1 to 0.5% per aligned sequence read (Table 2). Approximately
12% to 33% of NEs found were located in dbSNP and can
therefore be classified as known SNPs [14]. We also compared the
NEs pairwise under consideration of an at least 8fold coverage and
identified up to 90% ‘common SNPs’ for samples ID-02.15 and
ID-02.48 (Table 2). The absolute amount of called SNPs appears
Figure 1. Distribution of sequencing fragments for DNA extracted from snap frozen and FFPE breast tissues. (A) Shown are the
distributions of sequencing fragments over chromosome 1 using three different tissue conservation techniques Left: Snap frozen tissues, middle:
FFPE tissue with 20 min. ischemia, and right: FFPE tissue with 60 min. ischemia. The red line depicts median genome coverage. (B) Chromosomal
coverage ratio of snap frozen versus FFPE preparations of normal tissue samples. Each chromosome has been split into equal sized bins of 50 Kb size.
The log2 ratios of unique reads per bin have been plotted across all chromosomes.
doi:10.1371/journal.pone.0005548.g001
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identified. This is most likely due to DNA damage of the FFPE
samples. By increasing the sequence depth of the samples the
overlap between NEs for snap frozen and FFPE DNA increases,
suggesting that with an increase of sequence coverage the rate of
false positive calls in FFPE can be minimized (Supplementary
Figure S3). The amount of specific NE rates such as A to G or C to
A varies between 5% and 14%. However, the amounts of specific
NE rates were comparable in different sequencing settings with an
average standard deviation of 0.7%. The reproducibility of specific
NE rates was also found in the comparison of snap frozen and
FFPE tissue DNA as shown in Figure 3 and Table 3. A higher
variability of NEs in FFPE tissue samples is largely due to extended
fixation times since we have included all available sequencing data
from table 1 in our calculations. For both tissue preparation
techniques we found corresponding NE rates, suggesting that
FFPE tissues can also be used for mutational analyses. Filtering for
homozygous mutations, we found approximately 5% of all SNPs
with sequencing coverage rates greater than 8-fold and we were
able to repeatedly detect approximately 90% of the mutations in
both snap frozen and FFPE tissue preparations. As expected, the
absolute amount of known SNPs increased with the number of
sequencing fragments aligned for both snap frozen as well as FFPE
tissues. This again demonstrates the applicability and scalability of
second generation sequencing techniques for the detection of
mutations in FFPE tissues.
Taken together, our results illustrate that DNA extracted from
FFPE tissue can be used for second generation re-sequencing
approaches. We also demonstrated the possibility of gathering
information about CNAs and mutations with one single
sequencing effort from snap frozen as well as FFPE preserved
tissue types and proved that the data obtained from both
preparation methods is of comparable quality.
Discussion
In this paper, we investigated if new and archived FFPE tissues
could be used in addition to snap frozen tissues for massively
parallel sequencing and what requirements need to be fulfilled for
their use. We conclude that DNA extracted from FFPE tissues can
be used for Sequencing by Synthesis (SBS) and that neither an
increase in ischemia time from 20 min. to over 360 min. nor a
longer fixation time of up to 72 hours plays a major role in
sequencing quality (Figure 1, Table 1). Overall, the percentage of
unique mappable reads was in the same range for snap frozen and
paraffin-embedded samples. In general, we see variations in
mappable reads independent of the DNA source. However, for
FFPE samples the variability might also be partly due to DNA
damages resulting in more fragments with one or more
mismatches. Even though the absolute numbers of unique
alignments is slightly smaller for DNA extracted from FFPE
tissues, the fragments are evenly distributed over the genome and
Figure 3. Nucleotide exchange rates in DNA from snap frozen and FFPE tissues. Using the Maq 0.7.1 software nucleotide exchanges were
calculated for all possible transitions (e.g. A.G, A.C) for four snap frozen (SF) and five FFPE tissue samples [18]. Shown are boxblots with NE rates as
fractions of all mutations found per patient sample.
doi:10.1371/journal.pone.0005548.g003
Figure 2. Copy number variations in DNA from snap frozen and FFPE cancer tissues in relation to normal tissue. (A) DNA fragment
coverage ratio of tumor versus normal tissue on five chromosomes. The x-axis represents the genomic position. The y-axis represents the log2 ratio of
fragments per bin of tumor versus normal tissue. The fragment numbers are calculated per 120 Kb segment. The red lines depict the local averages
as calculated by DNAcopy [12]. Local differences in copy numbers exceeding two standard deviations are highlighted. (B) Detailed view of the
fragment distribution of chromosome 8 from snap frozen and FFPE breast cancer tissue samples.
doi:10.1371/journal.pone.0005548.g002
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tissue samples stored over 18 years in pathology departments can
be successfully sequenced and integrated in re-sequencing
programs. This provides an excellent opportunity to evaluate
tissue samples which have been collected and stored in biobanks
for clinical trials with anti cancer drugs. For instance, it has
become evident that the response to inhibitors of receptor tyrosine
kinases or inhibitors of downstream signaling molecules not only
depends on the expression of the drug target itself but also on the
presence of mutations or polymorphisms in functional domains of
the target [15] and its down stream signaling network [11].
The power of large-scale sequencing techniques not only lies in
the large amount of sequencing throughput but also in the
possibility to gain multi-faceted data of genomic, epigenomic and
transcriptomic origin.
As an example of the type of genome-based information that
can be obtained, we presented the successful calculation of copy
number alterations and mutations from snap frozen as well as from
FFPE breast tumor tissue. Copy number alterations in breast
cancer tissue were found equally well in snap frozen and FFPE
prepared tissue (Figure 2).
A patient-wise comparison of snap frozen and FFPE tissues with
regard to called mutations demonstrated concordance for 81 to
95% of mutations found in both preparation types given an
eightfold coverage rate. The comparable mutation rates and
frequencies for each transition and transversion again demon-
strated the reproducibility of the sequencing results in different
preparation settings (Table 2). The detection limit depended upon
the coverage rate calculated for technical replicates of snap frozen
and FFPE tissues (data not shown), indicating that the number of
consistently detected mutations in both tissue preparations could
be increased beyond 90%.
Formalin-fixed and paraffin-embedded tissue has not been used
in large-scale sequencing protocols. Our study demonstrated that
it can be reliably employed for highly relevant clinical problems
such as the combined investigation of CNAs and SNPs in scarce
tissue samples.
Our observation that long-term storage of samples has no
significant negative effect on sequencing results implies that it is
possible to re-evaluate FFPE-samples from participants in previous
clinical trials. In this way, DNA sequence-based biomarkers might
be established which discriminate responders and non-responders
to therapy, thereby contributing to a better targeted and more
efficacious application of new therapeutic treatments. In addition,
the determination of CNAs as well as mutations is not only
essential for tumor diagnosis, but is also required for the diagnosis
of a diverse array of genetic disorders associated with deletions or
gains of DNA such as trisomy 21 and microdeletions-syndrome
CATCH22 or with mutations such as Marfan’s Syndrome.
In summary, our results illustrate that DNA extracted from
FFPE tissue can be used for copy number analysis as well as
mutation analysis. Determining CNAs and mutations with one
single sequencing effort renders our method very efficient in terms
of time and money. The applicability and scalability of second
generation sequencing techniques is a major improvement for the
analysis of archived tissue material from biobanks and will lead to
the application of large-scale sequencing techniques as routine
diagnostic tools in general genetic counseling and oncology.
Materials and Methods
Ethics statement
The study has been approved by the Ethical Committee of the
Medical University of Graz (ethics statement #20-066 signed by
Prof.Dr. P.H. Rehak and Prof. DDr. H.P. Kapfhammer). For new
samples patients have given their written informed consent. For
old samples (14 and 18 years old) no informed consent was
available, therefore all samples and medical data used in this study
have been irreversibly anonymized.
Tissue storage
Human tissues obtained during surgery were divided into
several aliquots which were either snap frozen in methyl butane at
the temperature of liquid nitrogen or fixed in 4% buffered
(pH 7.4) formaldehyde for 24 and 72 hrs and embedded in
paraffin using an automated embedding system immediately after
surgery (,20 min cold ischemia time). To simulate the impact of
cold ischemia – samples were kept for 1 hr, 3 hrs and 6 hrs in a
humidified chamber at room temperature before freezing. The
impact of long-term storage (1 yr compared to 14 yrs and 18 yrs)
of FFPE samples was investigated in samples retrieved from the
tissue bank of the Institute of Pathology [16].
DNA preparation
From frozen tissue samples cryo sections of 3 mm thickness were
produced and stained with haematoxylin eosin to evaluate tumor
cell content. Further cryo sections were collected and processed for
DNA isolation using the QIAamp DNA Mini Kit (Qiagen),
according to the manufacturer’s instructions.
DNA was isolated from FFPE samples after extraction of 3 mm
thick paraffin sections in xylene and by using the QIAamp DNA
Mini Kit (Qiagen) PicoPure DNA Extraction Kit (Molecular
Devices) and the Macherey-Nagel DNA extraction protocol
following the same protocol as applied for frozen samples.
Illumina Genome Analyzer (Solexa) library preparation
and sequencing
Preparation of the libraries and sequencing were performed
using the Solexa sequencing platform (GenomeAnalyzer, Illumina)
following the manufacturer’s instructions. We randomly sheared
1,5 mg genomic DNA to fragments less than 800 bp. The
fragmented DNA was end-repaired using T4 DNA polymerase
and Klenow polymerase with T4 polynucleotide kinase activity to
Table 3. NE for samples ID-1.0 (snap forzen) and ID-1.1
(FFPE).
NE Snap Frozen FFPE
Count Fraction Count Fraction
ARC 290 8.4% 582 8.5%
ARG 506 14.7% 866 12.6%
ART 257 7.5% 570 8.3%
CRA 173 5.0% 429 6.3%
CRG 235 6.8% 529 7.7%
CRT 243 7.1% 435 6.3%
GRA 266 7.7% 512 7.5%
GRC 226 6.6% 495 7.2%
GRT 150 4.4% 396 5.8%
TRA 232 6.7% 547 8.0%
TRC 571 16.6% 935 13.6%
TRG 296 8.6% 566 8.2%
3445 6862
doi:10.1371/journal.pone.0005548.t003
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created using a exonuclease negative Klenow fragment and
Illumina adaptor oligonucleotides were ligated to the sticky ends.
Ligation products were purified by an agarose gel electrophoresis
and enriched for successfully ligated fragments with an 18-cycle
PCR using sequencing primers on either end. Ligation products
were then used for cluster generation and sequencing- by-
synthesis using the Illumina Genome Analyzer (Solexa) .
Bioinformatics data analysis
Image Analysis and base calling were performed using Firecrest
1.9.5_14 and Bustard 1.9.5_14 and reads were aligned to the human
genome (NCBI36) using Bowtie 0.9.7.1 [17]. The chromosomal
coverage was determined by splitting each chromosome in equally
sized regions (bins) and counting the reads that mapped equally to
each bin. The coverage comparison of different FFPE preparation
protocols was visualized using 300 bins per chromosome.
To compare the read coverage of different samples across all
chromosomes we counted uniquely mapped reads for five different
binsizes (50 Kb, 100 Kb, 250 Kb, 500 Kb, 1 Mb). As metric of
comparison we used the Pearson correlation coefficient on the
counts per bin. In detail, we determined the Pearson coefficient for
each chromosome separately and calculated the median across all
chromosomes. Stratification of bincount correlation by GC
content was done by calculating the Pearson correlation coefficient
across all bins of a certain GC content independent of
chromosomal location.
Copy number analysis was done in R using the DNAcopy
package [12]. In short, DNA read frequencies were determined for
bins of 120 Kb. The log2 frequency ratio of corresponding bins was
calculated for tumor versus normal tissue. Median of ratios was
centered to zero experiment wise. Log ratios were smoothed by
DNAcopy using default values and copy number variation was
detected by DNAcopy using a threshold of two standard deviations.
Overall nucleotide exchanges were calculated using the Maq
0.7.1 software with default parameters for the steps cns2snp &
SNPfilter [18]. Homozygous mutations detected in snap frozen
and FFPE prepared material with at least 8-fold coverage in both
samples were then compared patient wise. For the determination
of the detection limit homozygous mutations in technical replicates
for snap frozen and FFPE were compared.
Supporting Information
Figure S1 Dependency of coverage correlation coefficients of
snap frozen and FFPE tissues on GC content and bin size. The
GC content and the corresponding coverage correlation coeffi-
cients for bin sizes of 50, 100, 250, 500 and 1000 Kb were
calculated for snap frozen and FFPE tissues. Shown is one plot for
each bin size with the GC content on the x-axis, the Pearson
correlation coefficients as circles and the GC content per bin-
distribution as a histogram. A locally weighted polynomial
regression (LOESS) has been fitted to visualize trends.
Found at: doi:10.1371/journal.pone.0005548.s001 (0.51 MB TIF)
Figure S2 Dependency of coverage correlation coefficients from
two technical replicates on GC content and bin size. The GC
content and the corresponding coverage correlation coefficients
for bin sizes of 50, 100, 250, 500 and 1000 Kb were calculated for
two technical replicates. Shown is one blot for each bin size with
the GC content on the x-axis, the Pearson correlation coefficients
as circles and the GC content per bin-distribution as a histogram.
A locally weighted polynomial regression (LOESS) has been fitted
to visualize trends.
Found at: doi:10.1371/journal.pone.0005548.s002 (0.50 MB TIF)
Figure S3 The amount of SNPs found common in FFPE and
snap frozen preparations increases with higher coverage rates.
Intersections between two samples were calculated under
consideration of 4-fold, 8-fold and 12-fold coverages. Open
triangle: ID1.0 against ID1.3, closed circles: ID1.0 vs ID1.1,
closed rectangle: ID22.1 against ID 22.2, Open rectangle: ID-
02.15 against ID-02.48, stars: ID-02.14 against ID-02.58.
Found at: doi:10.1371/journal.pone.0005548.s003 (0.11 MB TIF)
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